샘플 요청 목록

 카트 문의
시장보고서
상품코드
1773949

세계의 전장 유전체 시퀀싱 시장

Whole Genome Sequencing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 464 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전장 유전체 시퀀싱 세계 시장은 2030년까지 58억 달러에 달할 전망

2024년에 21억 달러로 추정되는 전장 유전체 시퀀싱 세계 시장은 2024년부터 2030년까지 CAGR 19.0%로 성장하여 2030년에는 58억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 기기는 CAGR 16.6%를 기록하며 분석 기간 종료시에는 28억 달러에 달할 것으로 예측됩니다. 소모품 부문의 성장률은 분석 기간 동안 CAGR 22.1%로 추정됩니다.

미국 시장은 5억 6,030만 달러로 추정, 중국은 CAGR 25.3%로 성장 예측

미국의 전장 유전체 시퀀싱 시장은 2024년에는 5억 6,030만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 13억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 25.3%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 각각 분석 기간 동안에 15.4%와 16.8%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 CAGR 15.8%로 성장할 것으로 예측됩니다.

전 세계 전장 유전체 시퀀싱 시장 - 주요 동향 및 촉진요인 정리

전장 유전체 시퀀싱이 유전체학 분야를 변화시키는 이유는?

전장 유전체 시퀀싱(WGS)은 개인의 전체 유전자 코드에 대한 종합적인 분석을 제공함으로써 유전자 연구, 진단 및 맞춤형 의료에 혁명을 일으켰습니다. 특정 유전자에 초점을 맞춘 표적 염기서열 분석과 달리, WGS는 생물체 내의 모든 DNA 염기서열을 조사하여 유전적 변이, 질병 위험, 진화적 형질에 대한 더 깊은 인사이트를 제공합니다. 유전성 질환, 희귀 질환, 암의 유병률이 증가함에 따라 의료 서비스 제공자가 보다 정확하고 맞춤화된 치료 접근법을 요구함에 따라 임상 진단에서 WGS에 대한 수요가 증가하고 있습니다. 또한, 약물유전체학 분야에서는 WGS를 활용하여 개인의 유전적 체질에 따라 약물 처방을 조정하여 부작용을 줄이고 치료 효과를 향상시키고 있습니다. 농업, 미생물학, 법의학에서의 유전체 데이터 활용 확대도 WGS의 적용 범위를 넓히고 있습니다. 시퀀싱 비용이 지속적으로 감소하고 유전체 분석을 위한 계산 도구가 개선됨에 따라 WGS는 의학 및 과학 연구의 주류 도구가 되어 정밀 의학의 획기적인 발전을 위한 길을 열어가고 있습니다.

AI와 클라우드 컴퓨팅은 어떻게 전장 유전체 서열을 강화할 수 있을까?

인공지능(AI)과 클라우드 컴퓨팅의 통합으로 전장 유전체 시퀀싱의 효율성과 확장성이 크게 향상되었으며, AI 기반 알고리즘은 방대한 유전체 데이터세트를 분석하는 데 사용되어 더 높은 정확도와 속도로 질병 마커와 유전적 돌연변이를 식별합니다. 또한, 머신러닝 모델은 유전자 프로파일을 기반으로 질병 위험을 예측하고 개인화된 치료 계획을 추천하기 위해 적용되고 있습니다. 클라우드 컴퓨팅은 대규모 유전체 데이터세트의 저장과 공유를 용이하게 하고, 연구자와 의료진이 서로 다른 장소에서 실시간으로 협업할 수 있도록 했습니다. 또한, 안전한 유전체 데이터 관리를 위해 블록체인 기술이 검토되고 있으며, 프라이버시와 유전자 정보의 윤리적 사용을 보장하고 있습니다. 고처리량 시퀀싱 플랫폼과 자동화된 생물정보학 파이프라인의 채택으로 WGS의 속도는 더욱 빨라지고 있으며, 임상과 연구 모두에서 보다 접근하기 쉽고 비용 효율적입니다. AI와 빅데이터 분석이 계속 진화하고 있습니다. 이에 따라 의료 및 바이오테크놀러지에 혁명을 가져올 WGS의 가능성은 계속 확대되고 있습니다.

전장 유전체 시퀀싱의 보급을 가로막는 과제는 무엇일까?

전장 유전체 시퀀싱은 그 혁신적 잠재력에도 불구하고 비용, 데이터 프라이버시, 윤리적 문제 등의 문제에 직면해 있습니다. 시퀀싱 비용은 최근 몇 년 동안 크게 낮아졌지만, 특히 자원이 부족한 의료 환경에서는 임상에서 널리 활용되기에는 여전히 장벽으로 작용하고 있습니다. 대규모 유전체 데이터를 관리하고 해석하기 위해서는 전문적인 전문 지식과 고도의 컴퓨팅 인프라가 필요하며, 소규모 연구 기관이나 의료 서비스 제공자가 접근할 수 있는 범위가 제한되어 있습니다. 또한, 유전체 정보는 매우 민감하고 동의, 데이터 소유권, 악용 가능성에 대한 윤리적 문제가 발생하기 때문에 데이터 프라이버시에 대한 우려도 큰 문제입니다. 또한, 유전체 검사 및 데이터 공유에 대한 규제 프레임워크가 지역마다 다르기 때문에 세계 표준화에 걸림돌이 되고 있습니다. 이러한 과제를 해결하기 위해서는 비용 절감 전략에 대한 지속적인 투자, 데이터 보안 대책 강화, 기술 혁신과 환자의 권리 및 프라이버시 사이의 균형을 맞추는 윤리적 가이드라인의 개발이 필요합니다.

전장 유전체 시퀀싱 시장의 성장을 촉진하는 요인은 무엇인가?

전장 유전체 시퀀싱 시장의 성장은 맞춤의료에 대한 수요 증가, 시퀀싱 기술의 발전, 연구 및 진단 분야에서의 적용 확대 등 여러 요인에 의해 주도되고 있습니다. 정밀의학 이니셔티브의 부상으로 임상 현장에서의 WGS 도입이 가속화되어 암, 유전성 질환, 감염성 질환에 대한 표적 치료가 가능해졌습니다. 차세대 및 3세대 시퀀싱 등 시퀀싱 플랫폼의 지속적인 개선으로 정확도, 속도, 가격이 향상되어 보다 많은 연구자와 임상의가 WGS를 쉽게 이용할 수 있게 되었습니다. 또한, 소비자 직접 유전자 검사의 확대는 개인 유전체학에 대한 관심을 불러일으키고 종합적인 유전자 분석에 대한 수요를 촉진하고 있습니다. 농업, 생명공학, 마이크로바이옴 연구에 WGS가 통합되면서 시장 기회는 더욱 다양해졌고, 유전체 시퀀싱은 과학적 발견과 기술 혁신을 위한 중요한 도구로 자리매김하고 있습니다. 전 세계 유전체 연구 노력이 강화되고 헬스케어가 데이터 기반 맞춤형 치료법으로 전환함에 따라 WGS 시장은 의료 및 바이오테크놀러지의 미래를 형성하며 큰 성장을 이룰 준비가 되어 있습니다.

부문

구성요소(장비, 소모품, 서비스), 유형(대형 전장 유전체 시퀀싱, 소형 전장 유전체 시퀀싱), 용도(인간 전장 유전체 시퀀싱, 식물 전장 유전체 시퀀싱, 동물 전장 유전체 시퀀싱, 미생물 전장 유전체 시퀀싱), 최종 용도(학술·연구기관, 병원·클리닉, 제약·바이오테크놀러지 기업, 기타)

조사 대상 기업 사례

  • Agilent Technologies, Inc.
  • BGI Genomics Co Ltd.
  • Complete Genomics
  • Element Biosciences
  • Eurofins Genomics Germany GmbH
  • GeneDx
  • GENEWIZ
  • Illumina, Inc.
  • Macrogen
  • Nebula Genomics

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가가 선별한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.31

Global Whole Genome Sequencing Market to Reach US$5.8 Billion by 2030

The global market for Whole Genome Sequencing estimated at US$2.1 Billion in the year 2024, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 22.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$560.3 Million While China is Forecast to Grow at 25.3% CAGR

The Whole Genome Sequencing market in the U.S. is estimated at US$560.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 25.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.4% and 16.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.8% CAGR.

Global Whole Genome Sequencing Market - Key Trends & Drivers Summarized

Why Is Whole Genome Sequencing Transforming the Field of Genomics?

Whole genome sequencing (WGS) has revolutionized genetic research, diagnostics, and personalized medicine by providing a comprehensive analysis of an individual’s entire genetic code. Unlike targeted sequencing methods that focus on specific genes, WGS examines all DNA sequences in an organism, enabling deeper insights into genetic variations, disease risks, and evolutionary traits. The increasing prevalence of genetic disorders, rare diseases, and cancer has driven demand for WGS in clinical diagnostics, as healthcare providers seek more accurate and personalized treatment approaches. Additionally, the field of pharmacogenomics is leveraging WGS to tailor drug prescriptions based on an individual’s genetic makeup, reducing adverse reactions and improving therapeutic efficacy. The growing use of genomic data in agriculture, microbiology, and forensic science has also expanded the scope of WGS applications. As sequencing costs continue to decline and computational tools for genome analysis improve, WGS is becoming a mainstream tool in medical and scientific research, paving the way for groundbreaking advancements in precision medicine.

How Are AI and Cloud Computing Enhancing Whole Genome Sequencing?

The integration of artificial intelligence (AI) and cloud computing has significantly enhanced the efficiency and scalability of whole genome sequencing. AI-driven algorithms are being used to analyze vast genomic datasets, identifying disease markers and genetic variations with greater accuracy and speed. Machine learning models are also being applied to predict disease risks and recommend personalized treatment plans based on genetic profiles. Cloud computing has facilitated the storage and sharing of large genomic datasets, enabling researchers and healthcare providers to collaborate in real time from different locations. Additionally, blockchain technology is being explored for secure genomic data management, ensuring privacy and ethical use of genetic information. The adoption of high-throughput sequencing platforms and automated bioinformatics pipelines has further accelerated the pace of WGS, making it more accessible and cost-effective for both clinical and research applications. As AI and big data analytics continue to evolve, the potential of WGS in revolutionizing medicine and biotechnology will only expand.

What Challenges Are Hindering the Widespread Adoption of Whole Genome Sequencing?

Despite its transformative potential, whole genome sequencing faces challenges related to cost, data privacy, and ethical concerns. While sequencing costs have dropped significantly in recent years, they remain a barrier for widespread clinical adoption, particularly in low-resource healthcare settings. The management and interpretation of large-scale genomic data require specialized expertise and advanced computational infrastructure, limiting accessibility for smaller research institutions and healthcare providers. Data privacy concerns also pose a major challenge, as genomic information is highly sensitive and raises ethical questions regarding consent, data ownership, and potential misuse. Additionally, regulatory frameworks governing genomic testing and data sharing vary across regions, creating hurdles for global standardization. Addressing these challenges requires continued investment in cost-reduction strategies, enhanced data security measures, and the development of ethical guidelines that balance innovation with patient rights and privacy.

What Factors Are Driving the Growth of the Whole Genome Sequencing Market?

The growth in the whole genome sequencing market is driven by several factors, including increasing demand for personalized medicine, advancements in sequencing technologies, and expanding applications in research and diagnostics. The rise of precision medicine initiatives has accelerated WGS adoption in clinical settings, enabling targeted therapies for cancer, genetic disorders, and infectious diseases. Continuous improvements in sequencing platforms, such as next-generation and third-generation sequencing, have enhanced accuracy, speed, and affordability, making WGS more accessible to a broader range of researchers and clinicians. Additionally, the expansion of direct-to-consumer genetic testing has fueled interest in personal genomics, driving demand for comprehensive genetic analysis. The integration of WGS in agriculture, biotechnology, and microbiome research has further diversified market opportunities, positioning genome sequencing as a key tool for scientific discovery and innovation. As global genomic research efforts intensify and healthcare moves toward data-driven personalized treatment approaches, the WGS market is poised for substantial growth, shaping the future of medicine and biotechnology.

SCOPE OF STUDY:

The report analyzes the Whole Genome Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Instruments, Consumables, Services); Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing); Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing); End-Use (Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Agilent Technologies, Inc.
  • BGI Genomics Co Ltd.
  • Complete Genomics
  • Element Biosciences
  • Eurofins Genomics Germany GmbH
  • GeneDx
  • GENEWIZ
  • Illumina, Inc.
  • Macrogen
  • Nebula Genomics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Whole Genome Sequencing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • The Rising Demand for Personalized Medicine Drives Growth in Whole Genome Sequencing
    • Technological Advancements in Sequencing Platforms Propel the Growth of the Whole Genome Sequencing Market
    • Expanding Applications of Whole Genome Sequencing in Oncology Accelerate Market Adoption
    • Government Initiatives to Support Precision Medicine and Genomics Propel the Whole Genome Sequencing Market
    • Growing Awareness of the Benefits of Early Genetic Testing for Disease Prevention Strengthens the Business Case for Whole Genome Sequencing
    • Decreasing Costs of Genome Sequencing Technology Drives Wider Adoption in Healthcare and Research
    • Integration of Artificial Intelligence (AI) in Whole Genome Sequencing Enhances Data Interpretation and Increases Market Potential
    • The Expansion of Genomic Databases and Biobanks Spurs Demand for Whole Genome Sequencing Services
    • The Increasing Focus on Genetic Research for Rare Diseases Drives Growth in Whole Genome Sequencing Applications
    • Rising Popularity of Direct-to-Consumer Genetic Testing Services Accelerates Consumer Demand for Whole Genome Sequencing
    • The Growth of Health and Wellness Apps That Include Genetic Testing as a Service Expands Addressable Market Opportunity for Genome Sequencing
    • Regulatory Advancements and Streamlined Approval Processes for Genetic Testing Create Opportunities for Whole Genome Sequencing
    • The Integration of Whole Genome Sequencing into Routine Healthcare Services Generates Stronger Demand for Genomic Solutions
    • Collaborations Between Pharmaceutical Companies and Genomics Providers Foster Growth in Whole Genome Sequencing for Drug Development
    • The Rising Importance of Whole Genome Sequencing in Research Institutions and Academic Settings Accelerates Market Expansion
    • The Growing Utilization of Whole Genome Sequencing in Reproductive Health, Including Prenatal Screening, Strengthens Market Demand
    • The Advent of Single-Cell Genomics and Its Synergy with Whole Genome Sequencing Expands Applications in Precision Medicine
    • Increasing Investment in Genomic Startups and Research Initiatives Promotes Innovation in Whole Genome Sequencing Technologies
    • The Demand for Whole Genome Sequencing in Agriculture for Crop Improvement and Animal Breeding Fuels Market Growth
    • The Role of Whole Genome Sequencing in Infectious Disease Research, Including Pathogen Genomics, Spurs Demand for Sequencing Solutions
    • The Rise of Global Health Challenges and the Need for Rapid Genomic Data to Track Infectious Disease Evolution Drives Whole Genome Sequencing Adoption
    • Growing Partnerships Between Public and Private Healthcare Organizations to Facilitate Genomic Data Access Supports Market Growth
    • Increasing Availability of Data for Genomic Research Drives Further Investment and Innovation in Whole Genome Sequencing Technologies
    • Consumer Privacy Concerns and Ethical Issues Surrounding Whole Genome Sequencing Data Create Challenges for Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Genome Sequencing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Large Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Large Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Large Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Small Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Small Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Small Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Human Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Human Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Human Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Plant Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Plant Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Plant Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Animal Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Animal Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Animal Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Microbial Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Microbial Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Microbial Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • JAPAN
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • CHINA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • EUROPE
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Whole Genome Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • FRANCE
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • GERMANY
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Spain 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Russia 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Whole Genome Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Australia 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • INDIA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 218: India Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: India 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: South Korea 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Whole Genome Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Argentina 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Brazil 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Mexico 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Whole Genome Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Iran 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Israel 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: UAE 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • AFRICA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: Africa 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제